Patient Pathfinder: Clinical Trials
Clinical Trials for Colon Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 171 active Colon Cancer trials
A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors
Study Type: Observational
Palbociclib and Cetuximab in Metastatic Colorectal Cancer
Study Type: Interventional Phase 2
A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment
Study Type: Interventional Phase 1
LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer
Study Type: Interventional Phase 1
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Study Type: Interventional Phase 1
Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients
Study Type: Interventional Early Phase 1
Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
Study Type: Interventional Phase 2
Young-Onset Colorectal Cancer
Study Type: Observational
There are 171 active Colon Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now